The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lenvatinib (LEN) plus pembrolizumab (PEMBRO) for early-line treatment of advanced/recurrent endometrial cancer (EC).
 
Vicky Makker
Honoraria - Eisai; Merck; Merck
Consulting or Advisory Role - ArQule; Eisai; Karyopharm Therapeutics; Merck; Takeda
Research Funding - AstraZeneca; Bristol-Myers Squibb; Eisai; Lilly; Merck; Takeda
Travel, Accommodations, Expenses - Eisai; Karyopharm Therapeutics; Merck
Other Relationship - IBM
 
Matthew H. Taylor
Consulting or Advisory Role - ArQule; Array BioPharma; Bayer; Blueprint Medicines; Bristol-Myers Squibb; Eisai; Loxo; Novartis; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Merck
 
Carol Aghajanian
Consulting or Advisory Role - Clovis Oncology; Eisai; Immunogen; Mersana; Roche; Tesaro
Research Funding - Abbvie (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)
 
Ana Oaknin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genmab; Immunogen; PharmaMar; Roche; Tesaro
Research Funding - Abbvie (Inst); Ability Pharma (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Amgen (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Clovis Oncology (Inst); Eisai (Inst); Regeneron (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; PharmaMar; Roche
 
James Mier
No Relationships to Disclose
 
Allen Lee Cohn
Honoraria - Bristol-Myers Squibb; Ipsen
Speakers' Bureau - Bristol-Myers Squibb; Ipsen
 
Margarita Romeo
Consulting or Advisory Role - AstraZeneca; Roche; Tesaro/GSK
Research Funding - Aprea AB (Inst); AstraZeneca (Inst); Eisai (Inst)
Travel, Accommodations, Expenses - MSD; Pfizer
 
Raquel Bratos
No Relationships to Disclose
 
Marcia S. Brose
Honoraria - Bayer
Consulting or Advisory Role - AstraZeneca; Bayer; Blueprint Medicines; Bristol-Myers Squibb; Eisai; Genzyme; Loxo; Novartis
Research Funding - Bayer (Inst); Blueprint Medicines (Inst); Eisai (Inst); Exelixis (Inst); Loxo (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Christopher DiSimone
No Relationships to Disclose
 
Mark Messing
Leadership - US Oncology
 
Lea Dutta
Employment - Eisai
Research Funding - Eisai
 
Min Ren
Employment - Eisai
 
Emmett V. Schmidt
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Robert Orlowski
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Bluebird Bio; Celgene; Merck Sharp & Dohme; Nektar; OncoSec
Research Funding - Merck Sharp & Dohme
 
Jodi Alicia McKenzie
Employment - Eisai
 
Kathryn Gillis
Employment - Eisai; Novartis
Stock and Other Ownership Interests - Novartis
 
Antonio Casado Herraez
Honoraria - AstraZeneca; Eisai; Lilly; MSD; PharmaMar; Roche; Tesaro
Consulting or Advisory Role - Eisai; MSD
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - Lilly; PharmaMar; Roche